Post-Authorization Study Evaluating Safety Of Tigecycline
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
This is a study to evaluate the safety of tigecycline in patients with complicated
intra-abdominal infections (cIAI) and complicated skin and soft tissue infections (cSSTI)
under real practice in the usual hospital setting and patients' conditions, in order to
assess the "real incidence" of adverse events related with tigecycline in these patients.